| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/30/2008 | CN101230340A 纤维蛋白溶解活性多肽 Fibrinolytic activity of the polypeptide |
| 07/30/2008 | CN101230339A Bombina maxima non-crystalline beta gamma-crystallin and trefoil factor protein compound and gene as well as preparation and use thereof |
| 07/30/2008 | CN101230100A Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/30/2008 | CN101230096A Peptide derived from hepatitis C virus |
| 07/30/2008 | CN101230095A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230094A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230093A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230092A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230091A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230090A Blood peptide X and derivative thereof as well as preparation method and use thereof |
| 07/30/2008 | CN101229380A Targeted delivery of drugs for the treatment of viral infections |
| 07/30/2008 | CN101229378A Compositon useful for delivery of active agents |
| 07/30/2008 | CN101229369A Antiatheroscloresis thrombolytic soft capsule and preparing method thereof |
| 07/30/2008 | CN101229368A Method of using proteinase to diabetic foot gangrene |
| 07/30/2008 | CN101229367A Process of preparing human fibrinogen preparation |
| 07/30/2008 | CN101229366A Applications of fibroblast growth factor on preparing vasculogenesis-promoting medicine |
| 07/30/2008 | CN101229365A Applications of nerve growth factor(NGF) on preparing medicine for treating pathological myopia |
| 07/30/2008 | CN101229364A Scorpion toxin spray and preparing method thereof |
| 07/30/2008 | CN101229363A Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 07/30/2008 | CN101229362A Use of thymulin on preparing protective medicine of antineoplastic agent, tumour physiatry and chemotherapeutic medicine |
| 07/30/2008 | CN101229320A Glutathione ammoniacum compounds and processing method thereof |
| 07/30/2008 | CN101229185A Medicine compounds for treating seriously disease |
| 07/30/2008 | CN100406891C 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离 Identification of isolated compounds utilizing EPF receptor binding or regulate the activity and hDRR of hDRR |
| 07/30/2008 | CN100406570C Sgk and Nedd used as diagnostic and therapeutic targets |
| 07/30/2008 | CN100406562C Humanized immunoglobulin reactive with alpha 4 beta 7 integrin |
| 07/30/2008 | CN100406558C Method for preparing recombinant aprotinin |
| 07/30/2008 | CN100406472C Fusion and solubility expression of cobratoxin and acidolysis release and purification of recombinant toxin |
| 07/30/2008 | CN100406470C Protein for causing sperm not wandering prepared from india worm lizard body cavity liquid |
| 07/30/2008 | CN100406468C Design of antisuppository KGD-cyclohepta-peptide, its preparation and use thereof |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406065C Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
| 07/30/2008 | CN100406059C Novel use of parathyroid hormone |
| 07/30/2008 | CN100406058C Placenta factor, preparation method and application |
| 07/30/2008 | CN100406057C Amelioration of effects of cigarette smoke |
| 07/30/2008 | CN100406037C Heterocarpin, a plant-derived protein with anti-cancer properties |
| 07/30/2008 | CN100406025C Pharmacal use of sex steroid antagonist and sex steroid agonist |
| 07/30/2008 | CA2619799A1 Methods for evaluating and implementing prostate disease treatments |
| 07/29/2008 | US7405292 Small, interfering RNA (siRNA) molecules which inhibit expression of HALP (HIV-Associated Life Preserver) protein cloned into a plasmid or retroviral vector for introduction into host cells; screening HIV-modulating componds which prevent apoptosis resistance of infected cell; gene therapy |
| 07/29/2008 | US7405289 Polynucleotide encoding polypeptide comprising proline/glutamine rich domain, an RFX DNA binding domain, an RFX B domain, an RFX C domain, a dimerization domain and a serine/threonine domain; drug screening ; gene therapy; promote differentiations into functioning beta-cells(insulin); diabetes diagnosis |
| 07/29/2008 | US7405288 V-like domain binding molecules and polynucleotides encoding therefor |
| 07/29/2008 | US7405286 An isolated polynucleotide encoding the STAR (a striated muscle activated of Rho signaling) polypeptide comprising SEQ ID NO:4; expression inhibition useful in therapy/prevention of cardiovascular disorders,e.g., myocardial infraction, heart failure, cardiac hypertrophy, dilated cardiomyopathy |
| 07/29/2008 | US7405279 Chimeric proteins for diagnosis and treatment of diabetes |
| 07/29/2008 | US7405278 Chimeric human-type vascular endothelial cell growth factor |
| 07/29/2008 | US7405272 Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligand (PSGL-1) binding protein |
| 07/29/2008 | US7405270 CD40-Ligand lacking native-pattern glycosylation |
| 07/29/2008 | US7405269 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 07/29/2008 | US7405238 Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | US7405205 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 07/29/2008 | US7405203 Pharmaceutical compositions including low dosages of desmopressin |
| 07/29/2008 | US7405202 CRISP polypeptides as contraceptives and inhibitors of sperm capacitation |
| 07/29/2008 | US7405201 Antibacterial macrocycles |
| 07/29/2008 | US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 07/29/2008 | US7405199 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 07/29/2008 | US7405198 Glycopegylated erythropoietin |
| 07/29/2008 | US7405197 Controlling embryos insertion; fertility therapy; concurrent administering with follicle stimulating hormone |
| 07/29/2008 | US7405196 administering a long acting insulin; also treating diabetic dyslipidemia and atherosclerosis in a patient with IFG, IGT or Type 2 diabetes, particularly early Type 2 diabetes |
| 07/29/2008 | US7405195 anti-wrinkle herbal extract contains extracts of a hop, a horsetail or both; whiting herbal extract contains root extract of a Scutellaria baicalensis, a Saxifrage sarmentosa, or both; anti-acne herbal extracts selected from a Watercress, a witch hazel, a centella or a licorice; polypeptide |
| 07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
| 07/29/2008 | US7405193 Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 07/29/2008 | US7405192 Difference between the amplified sequence and the normal gene sequence is diagnostic of glaucoma |
| 07/29/2008 | US7405080 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/29/2008 | US7405058 Thymic stromal lymphopoietin (TSLP); nucleic acid encoding polypeptide of given sequence; use in peptide fragmentation studies and molecular weight measurements |
| 07/29/2008 | US7405053 Modified amino acid sequence compared to the wild-type; interaction determined by detecting change in cellular signal; fusion proteins and vectors |
| 07/29/2008 | US7405049 Elevated concentration of given protein is indicative of sepsis or Alzheimer's disease; procalcitonin biomarker; immunoassay |
| 07/29/2008 | US7405048 Improving production by immunocompetent cells; side effect reduction |
| 07/29/2008 | US7404973 For use as dietary supplement, in drugs, soy protein concentrate |
| 07/29/2008 | US7404961 Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins |
| 07/29/2008 | US7404957 Interleukins; for treatment of respiratory disorders such as asthma, chronic obstructive pulmonary disease, emphysema, and bronchitis; improved plasma half-life |
| 07/29/2008 | US7404955 Methods of inhibiting or neutralizing TNFα in patients with tissue injury |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | US7404951 Intravenously administering glutamate modifying enzyme and co-factor to enhance brain to blood efflux; transaminase, dehydrogenase, decarboxylase, ligase |
| 07/29/2008 | US7404950 Induced activation in dendritic cell |
| 07/29/2008 | US7404948 Peptidic conjugates for alopecia prevention and treatment |
| 07/29/2008 | US7404796 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor |
| 07/29/2008 | US7404636 Electro-active spectacle employing modal liquid crystal lenses |
| 07/29/2008 | CA2413670C Human brain and testis-specific immunoglobulin superfamily (bt-igsf) cdna for diagnosis of aplasia of corpus callosum and aspermatogenesis |
| 07/29/2008 | CA2405486C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 07/29/2008 | CA2381729C Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 07/29/2008 | CA2375383C Modulators of methylation for control of bacterial virulence |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2367214C Method for a programmed controlled ovarian stimulation protocol |
| 07/29/2008 | CA2359592C Pharmaceutical compositions for alleviating discomfort |
| 07/29/2008 | CA2346825C Method for production of stroma-free hemoglobin |
| 07/29/2008 | CA2305597C Affinity markers for human serum albumin |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2254914C Methods of terminal sterilization of biological products |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/29/2008 | CA2223702C Therapeutic fragments of von willebrand factor |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2203033C Compounds and compositions for delivering active agents |
| 07/29/2008 | CA2201377C Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 07/29/2008 | CA2192543C Interleukin-5 specific recombinant antibodies |
| 07/29/2008 | CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/29/2008 | CA2141842C Novel glycoforms of soluble complement receptor 1 |
| 07/24/2008 | WO2008089494A2 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 07/24/2008 | WO2008089491A2 Modifications of peptide compositions to increase stability and delivery efficiency |
| 07/24/2008 | WO2008089234A2 Natural polypeptides for oral health care |